Page last updated: 2024-10-27

fenofibrate and Ear Diseases

fenofibrate has been researched along with Ear Diseases in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Ear Diseases: Pathological processes of the ear, the hearing, and the equilibrium system of the body.

Research Excerpts

ExcerptRelevanceReference
" Several studies have been conducted to attenuate the side effects of cisplatin; one such side effect in cancer patients undergoing cisplatin chemotherapy is ototoxicity."1.48Protective roles of fenofibrate against cisplatin-induced ototoxicity by the rescue of peroxisomal and mitochondrial dysfunction. ( Kim, SJ; Lee, JN; Park, C; Park, R, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, SJ1
Park, C1
Lee, JN1
Park, R1

Other Studies

1 other study available for fenofibrate and Ear Diseases

ArticleYear
Protective roles of fenofibrate against cisplatin-induced ototoxicity by the rescue of peroxisomal and mitochondrial dysfunction.
    Toxicology and applied pharmacology, 2018, 08-15, Volume: 353

    Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cisplatin; Cochlea; Ear Diseases; Evoked P

2018